The Germ Theory of Fitness

Why molecular benchmarks of functional capacity may be what medicine needs to truly improve healthspan

In 1847, a Hungarian physician named Ignaz Semmelweis made an observation that should have changed medicine overnight. Doctors who washed their hands before delivering babies reduced maternal deaths from puerperal fever dramatically. The behavior was identified. The intervention was cheap, and the evidence was real.

And almost nobody changed.

Semmelweis was ridiculed, dismissed, and eventually driven to a psychiatric institution. He died (ironically) from an infection, just two weeks after being admitted. It wasn’t until decades later, when Pasteur and Lister developed germ theory: a coherent molecular explanation for why pathogens caused disease, that physicians bought in and handwashing was finally adopted at scale.

The lesson isn’t just a medical history curiosity. It’s a blueprint for understanding why good evidence, absent a satisfying mechanistic framework, rarely changes behavior— even (especially) among experts.

I’ve been thinking about this a lot in the context of the role of fitness in medicine.

The Evidence Is Already There

The data on exercise is, at this point, overwhelming. Cardiorespiratory fitness, most precisely captured by VO₂max, is among the strongest predictors of all-cause mortality we have. A landmark 2018 study in JAMA Network Open found that low cardiorespiratory fitness was associated with a greater risk of death than smoking, hypertension, or diabetes. Study after study links regular physical activity with reduced risk of cardiovascular disease, metabolic syndrome, cognitive decline, and several cancers. I’ve written a lot about this previously.

We’ve known this for decades. And yet physical fitness remains largely absent from mainstream clinical medicine. It isn’t routinely measured. It isn’t formally prescribed with the precision we apply to pharmacotherapy. It isn’t reimbursed with anywhere near the enthusiasm of a new drug approval.

Semmelweis would recognize this pattern immediately.

What’s Been Missing: A Molecular Framework

Here’s the part that I think explains a lot of the disconnect: nearly all of our current molecular diagnostics, our biomarkers, our omics panels, our liquid biopsies, were developed in service of reductionist pharmaceutical interventions. Elevated LDL leads to a statin prescription. An HbA1c above threshold leads to metformin. Circulating tumor DNA leads to targeted therapy. The molecular layer was built to support drug pipelines, not lifestyle pipelines.

That means when a cardiologist or endocrinologist looks at a patient’s lab panel, the implicit question embedded in the data is: what do I prescribe? There is no equivalent molecular infrastructure that asks: what does this person’s biology tell us about their functional capacity, and what training or nutrition intervention would move it?

This isn’t a failure of the science. It’s a failure of instrumentation.

Omics as the Germ Theory of Fitness

What multi-omic approaches (proteomics, metabolomics, transcriptomics, and their integration) are beginning to offer is something genuinely new: a molecular window into functional capacity. Not just disease risk. Not just static biomarkers of pathology. But dynamic readouts of how a body adapts, recovers, and performs.

Proteins that reflect mitochondrial capacity. Metabolites that track substrate utilization under physiological stress. Gene expression signatures that distinguish a trained from a sedentary phenotype at the cellular level. These aren’t theoretical. The data are accumulating rapidly.

What they begin to provide is a mechanistic explanation for something we already know behaviorally: that fitness works. And importantly, they provide individualized benchmarks: a molecular portrait of where someone sits on the functional capacity spectrum, and what moving that needle actually looks like at the biological level.

This is the germ theory moment for fitness. Not because the behavior was in doubt, but because the molecular substrate that explains and guides the behavior has been missing from clinical medicine.

How Omics of Functional Capacity Will Change Practice

Once you have molecular benchmarks tied to functional capacity, several things follow naturally. Fitness interventions become prescribable with precision — tailored to an individual’s metabolic phenotype rather than applied generically. Nutrition protocols can be evaluated against biological readouts, not just self-reported outcomes. The field gains the rigor that pharmacological development has long demanded of itself.

More importantly, it changes the frame for the clinician. The question shifts from “should I recommend exercise?” which most physicians already answer yes in theory, to “what does this specific patient’s biology tell us about where to intervene, and how do we measure whether it’s working?”

That is the difference between Semmelweis handing out pamphlets and Pasteur publishing the germ theory.

Preventive and performance medicine has an opportunity right now to be part of the next wave of molecular medicine, rather than watching it arrive from the sidelines. The behavioral insight — that fitness is medicine — has been in hand for decades.

The framework that will make it stick is finally within reach.